CNM-Au8 in Amyotrophic Lateral Sclerosis

Overview of attention for article published in JAMA: Journal of the American Medical Association, February 2025

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

So far, Altmetric has seen 4 public wall posts from 3 users.

CNM-Au8, an oral suspension of catalytically active gold particles, did not improve the primary efficacy outcome of amyotrophic…

From JAMA: CNM-Au8, an oral suspension of catalytically active gold particles, did not improve the primary efficacy outcome of…

CNM-Au8, an oral suspension of catalytically active gold particles, did not improve the primary efficacy outcome of amyotrophic…

From JAMA: CNM-Au8, an oral suspension of catalytically active gold particles, did not improve the primary efficacy outcome of…

This page shows the most recent Facebook posts that mention this research output. Click here to find out how to access more activity.